Cargando…

Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity

BACKGROUND: Serine hydroxymethyltransferase 2 (SHMT2) catalyzes the reversible conversion of tetrahydrofolate (THF) and serine-producing THF-conjugated one-carbon units and glycine in the mitochondria. Biallelic SHMT2 variants were identified in humans and suggested to alter the protein’s active sit...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiddler, Joanna L., Blum, Jamie E., Heyden, Katarina E., Castillo, Luisa F., Thalacker-Mercer, Anna E., Field, Martha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037823/
https://www.ncbi.nlm.nih.gov/pubmed/36959541
http://dx.doi.org/10.1186/s12263-023-00724-3
_version_ 1784911957266006016
author Fiddler, Joanna L.
Blum, Jamie E.
Heyden, Katarina E.
Castillo, Luisa F.
Thalacker-Mercer, Anna E.
Field, Martha S.
author_facet Fiddler, Joanna L.
Blum, Jamie E.
Heyden, Katarina E.
Castillo, Luisa F.
Thalacker-Mercer, Anna E.
Field, Martha S.
author_sort Fiddler, Joanna L.
collection PubMed
description BACKGROUND: Serine hydroxymethyltransferase 2 (SHMT2) catalyzes the reversible conversion of tetrahydrofolate (THF) and serine-producing THF-conjugated one-carbon units and glycine in the mitochondria. Biallelic SHMT2 variants were identified in humans and suggested to alter the protein’s active site, potentially disrupting enzymatic function. SHMT2 expression has also been shown to decrease with aging in human fibroblasts. Immortalized cell models of total SHMT2 loss or folate deficiency exhibit decreased oxidative capacity and impaired mitochondrial complex I assembly and protein levels, suggesting folate-mediated one-carbon metabolism (FOCM) and the oxidative phosphorylation system are functionally coordinated. This study examined the role of SHMT2 and folate availability in regulating mitochondrial function, energy metabolism, and cellular proliferative capacity in both heterozygous and homozygous cell models of reduced SHMT2 expression. In this study, primary mouse embryonic fibroblasts (MEF) were isolated from a C57Bl/6J dam crossed with a heterozygous Shmt2(+/−) male to generate Shmt2(+/+) (wild-type) or Shmt2(+/−) (HET) MEF cells. In addition, haploid chronic myeloid leukemia cells (HAP1, wild-type) or HAP1 cells lacking SHMT2 expression (ΔSHMT2) were cultured for 4 doublings in either low-folate or folate-sufficient culture media. Cells were examined for proliferation, total folate levels, mtDNA content, protein levels of pyruvate kinase and PGC1α, pyruvate kinase enzyme activity, mitochondrial membrane potential, and mitochondrial function. RESULTS: Homozygous loss of SHMT2 in HAP1 cells impaired cellular folate accumulation and altered mitochondrial DNA content, formate production, membrane potential, and basal respiration. Formate rescued proliferation in HAP1, but not ΔSHMT2, cells cultured in low-folate medium. Pyruvate kinase activity and protein levels were impaired in ΔSHMT2 cells and in MEF cells exposed to low-folate medium. Mitochondrial biogenesis protein levels were elevated in Shmt2(+/−) MEF cells, while mitochondrial mass was increased in both homozygous and heterozygous models of SHMT2 loss. CONCLUSIONS: The results from this study indicate disrupted mitochondrial FOCM impairs mitochondrial folate accumulation and respiration, mitochondrial formate production, glycolytic activity, and cellular proliferation. These changes persist even after a potentially compensatory increase in mitochondrial biogenesis as a result of decreased SHMT2 levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-023-00724-3.
format Online
Article
Text
id pubmed-10037823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100378232023-03-25 Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity Fiddler, Joanna L. Blum, Jamie E. Heyden, Katarina E. Castillo, Luisa F. Thalacker-Mercer, Anna E. Field, Martha S. Genes Nutr Research BACKGROUND: Serine hydroxymethyltransferase 2 (SHMT2) catalyzes the reversible conversion of tetrahydrofolate (THF) and serine-producing THF-conjugated one-carbon units and glycine in the mitochondria. Biallelic SHMT2 variants were identified in humans and suggested to alter the protein’s active site, potentially disrupting enzymatic function. SHMT2 expression has also been shown to decrease with aging in human fibroblasts. Immortalized cell models of total SHMT2 loss or folate deficiency exhibit decreased oxidative capacity and impaired mitochondrial complex I assembly and protein levels, suggesting folate-mediated one-carbon metabolism (FOCM) and the oxidative phosphorylation system are functionally coordinated. This study examined the role of SHMT2 and folate availability in regulating mitochondrial function, energy metabolism, and cellular proliferative capacity in both heterozygous and homozygous cell models of reduced SHMT2 expression. In this study, primary mouse embryonic fibroblasts (MEF) were isolated from a C57Bl/6J dam crossed with a heterozygous Shmt2(+/−) male to generate Shmt2(+/+) (wild-type) or Shmt2(+/−) (HET) MEF cells. In addition, haploid chronic myeloid leukemia cells (HAP1, wild-type) or HAP1 cells lacking SHMT2 expression (ΔSHMT2) were cultured for 4 doublings in either low-folate or folate-sufficient culture media. Cells were examined for proliferation, total folate levels, mtDNA content, protein levels of pyruvate kinase and PGC1α, pyruvate kinase enzyme activity, mitochondrial membrane potential, and mitochondrial function. RESULTS: Homozygous loss of SHMT2 in HAP1 cells impaired cellular folate accumulation and altered mitochondrial DNA content, formate production, membrane potential, and basal respiration. Formate rescued proliferation in HAP1, but not ΔSHMT2, cells cultured in low-folate medium. Pyruvate kinase activity and protein levels were impaired in ΔSHMT2 cells and in MEF cells exposed to low-folate medium. Mitochondrial biogenesis protein levels were elevated in Shmt2(+/−) MEF cells, while mitochondrial mass was increased in both homozygous and heterozygous models of SHMT2 loss. CONCLUSIONS: The results from this study indicate disrupted mitochondrial FOCM impairs mitochondrial folate accumulation and respiration, mitochondrial formate production, glycolytic activity, and cellular proliferation. These changes persist even after a potentially compensatory increase in mitochondrial biogenesis as a result of decreased SHMT2 levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-023-00724-3. BioMed Central 2023-03-24 /pmc/articles/PMC10037823/ /pubmed/36959541 http://dx.doi.org/10.1186/s12263-023-00724-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Fiddler, Joanna L.
Blum, Jamie E.
Heyden, Katarina E.
Castillo, Luisa F.
Thalacker-Mercer, Anna E.
Field, Martha S.
Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title_full Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title_fullStr Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title_full_unstemmed Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title_short Impairments in SHMT2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
title_sort impairments in shmt2 expression or cellular folate availability reduce oxidative phosphorylation and pyruvate kinase activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037823/
https://www.ncbi.nlm.nih.gov/pubmed/36959541
http://dx.doi.org/10.1186/s12263-023-00724-3
work_keys_str_mv AT fiddlerjoannal impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity
AT blumjamiee impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity
AT heydenkatarinae impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity
AT castilloluisaf impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity
AT thalackermercerannae impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity
AT fieldmarthas impairmentsinshmt2expressionorcellularfolateavailabilityreduceoxidativephosphorylationandpyruvatekinaseactivity